• 373645-86-4
    (5Z,13Z)-(2R,3R,4S,8S,9R,10R,11S,12S)-3,9-bis(tertbutyldimethylsilanyloxy)-11-hydroxy-2,4,6,8,10,12-hexamethylhexadeca-5,13,15-trienal
  • 496035-46-2
    (3Z,5S,6S,7S,8Z,11S,12R,13S,14S,15S,16Z)-6,12-bis(tert-butyldimethylsilyloxy)-5,7,9,11,13,15-hexamethyl-14-hydroxynonadeca-3,8,16,18-tetraen-2-one

  • 参考文献

    NOVARTIS AG; NOVARTIS PHARMA GMBH; CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LTD. Patent: WO2004/9574 A1, 2004

  • 上一页
  • 1
  • 2
  • 3
  • ...
  • 15
  • 下一页